Hans van der Lelie
- Pathology and Forensic Medicine top 0.5%
- Oncology top 2%
- Hematology top 1%
- Genetics top 1%
- Neurology top 2%
- Co-authors
- Pieter SonneveldCesare GuglielmiThierry PhilipAnton HagenbeekDominique BronFranck ChauvinJean‐Yves CahnJ L Harousseau
- Topics
- Neutropenia and Cancer Infections (7 papers)Chronic Lymphocytic Leukemia Research (5 papers)Lymphoma Diagnosis and Treatment (5 papers)
- Partner nations
- NetherlandsGermanyItaly
In The Last Decade
Hans van der Lelie
25 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Pathology and Forensic Medicine 1.8k
- Oncology 1.5k
- Hematology 980
- Genetics 704
- Neurology 586
Countries citing papers authored by Hans van der Lelie
This map shows the geographic impact of Hans van der Lelie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans van der Lelie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans van der Lelie more than expected).
Fields of papers citing papers by Hans van der Lelie
This network shows the impact of papers produced by Hans van der Lelie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans van der Lelie. The network helps show where Hans van der Lelie may publish in the future.
Co-authorship network of co-authors of Hans van der Lelie
This figure shows the co-authorship network connecting the top 25 collaborators of Hans van der Lelie. A scholar is included among the top collaborators of Hans van der Lelie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans van der Lelie. Hans van der Lelie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 345 | |
| 3 | 12 | |
| 4 | 24 | |
| 5 | 28 | |
| 6 | 28 | |
| 7 | 18 | |
| 8 | 115 | |
| 9 | 236 | |
| 10 | 36 | |
| 11 | 214 | |
| 12 | 11 | |
| 13 | Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphomabreakdown → | 1798 |
| 14 | 15 | |
| 15 | 77 | |
| 16 | 39 | |
| 17 | 17 | |
| 18 | 41 | |
| 19 | 3 | |
| 20 | 45 |
About Hans van der Lelie
Hans van der Lelie is a scholar working on Hematology, Genetics and Oncology, having authored 25 papers that have together received 3.2k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.8k citations), Hematology (980 citations) and Genetics (704 citations). Hans van der Lelie has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Pieter Sonneveld, Cesare Guglielmi, Thierry Philip, Anton Hagenbeek, Dominique Bron, Franck Chauvin, Jean‐Yves Cahn, J L Harousseau, F Mandelli and Pierre Biron. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.